Skip to content

The Future of Revascularization Using a Bioprotec Graft

The Future of the Revascularization Using a Bioprotec Graft

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04018846
Acronym
REVATEC
Enrollment
46
Registered
2019-07-15
Start date
2018-09-01
Completion date
2022-10-07
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Artery Disease

Keywords

Peripheral Artery Disease, Revascularization, Graft, Vein, Artery, Limb, Amputation

Brief summary

The main purpose of this study is the rate assessment of rescued limbs, one year after a BIOPROTEC vascular graft.

Detailed description

The BIOPROTEC grafts are controverted: they are useful in some cases, but they are known as frequently broken or thrombosed. However they are always posed in a complicated situations, in a fragile patients who have ever had many of revascularizations or in an infectious state (which is supportive of the pseudoaneurysm and thrombosis) Despite the frequent use of this graft in France, the results have never been published.

Interventions

PROCEDURERevascularization using a BIOPROTEC Graft

It is about a routine care study not changing the usual follow-up of patients: postoperative visits after a Doppler ultrasonography made by a vascular Doctor in 1 month, 6 months, 12 months, 18 months and 2 years.

Sponsors

Hôpital NOVO
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ Eighteen years old. * Critical ischemia (Phase 4-6 of Rutherford): no saphenous equipment for the vascular reconstruction; at least one leg axis permeable.

Exclusion criteria

* Pregnant woman. * Patient with an acute ischemia. * Patient with an exceeded ischemia.

Design outcomes

Primary

MeasureTime frameDescription
The Limb rescue rate one year after a BIOPROTEC graftTwo yearsUsual follow-up of patients: postoperative visits after a Doppler ultrasonography made by a vascular doctor in 1 month, 6 months, 12 months, 18 months and 2 years

Secondary

MeasureTime frameDescription
The revascularization permeability rateTwo yearsUsual follow-up of patients: postoperative visits after a Doppler ultrasonography made by a vascular doctor in 1 month, 6 months, 12 months, 18 months and 2 years
The amputation rateTwo yearsUsual follow-up of patients: postoperative visits after a Doppler ultrasonography made by a vascular doctor in 1 month, 6 months, 12 months, 18 months and 2 years
Infection resistance rateTwo yearsUsual follow-up of patients: postoperative visits after a Doppler ultrasonography made by a vascular doctor in 1 month, 6 months, 12 months, 18 months and 2 years

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026